May 10th 2024
A recently published study investigated the impacts of a branded probiotic from ADM, and a heat-treated postbiotic version of the same strain on diarrhea-predominant irritable bowel syndrome.
Recent study demonstrates potential of a synbiotic formulation for precision microbiome modulation
August 31st 2023The study was funded by Prolacta Bioscience and featured its synbiotic consisting of Bifidobacterium longum subspecies infantis (B. infantis) and human milk oligosaccharides (HMOs).
Probiotic strain from Probi may support metabolic health according to recent study
August 3rd 2023Results showed that compared to placebo, subjects taking the probiotic strain experienced a greater reduction in remnant cholesterol which is significantly associated with improvements in endothelial function.